Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality

NCT04101474 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04101474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04101474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2020
Completion date
October 1, 2021
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression